Brief: Bayer And Bicycle Therapeutics Enter Strategic Collaboration For Development Of Radiotherapy Drug Candidates

Bicycle Therapeutics

10/05/2023 13:45

May 10 (Reuters) - Bicycle Therapeutics PLC  BCYC.O :
    * BAYER AND BICYCLE THERAPEUTICS ENTER STRATEGIC
COLLABORATION FOR
DEVELOPMENT OF NOVEL TARGETED RADIONUCLIDE THERAPIES IN ONCOLOGY
    * BICYCLE THERAPEUTICS PLC: COLLABORATION WILL LEVERAGE
BICYCLE
THERAPEUTIC'S SYNTHETIC PEPTIDES
    * BICYCLE THERAPEUTICS PLC: TO RECEIVE UPFRONT PAYMENT OF
USD 45
MILLION
    * BICYCLE THERAPEUTICS : TO RECEIVE POTENTIAL FUTURE
DEVELOPMENT
AND COMMERCIAL-BASED MILESTONES, UP TO USD 1.7 BILLION, PLUS
TIERED COMMERCIAL ROYALTIES
    * BICYCLE THERAPEUTICS : AGREEMENT TO DISCOVER, DEVELOP,
MANUFACTURE, & COMMERCIALIZE BICYCLE RADIOCONJUGATES FOR
MULTIPLE AGREED UPON ONCOLOGY TARGETS

Source text for Eikon:  ID:nBw7RQtfya 
Further company coverage:  BCYC.O 

 ((Reuters.Briefs@thomsonreuters.com;))